These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18416009)

  • 1. FDA notifications. Tentative approval granted for combo antiretroviral drug.
    AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. Tentative approval of generic lamivudine.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA notifications. Tentative approval granted for lamivudine/stavudine.
    AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. Tentative approval granted of generic nevirapine.
    AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
    AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA notifications. Tentative approval to Aptivus for combination ART.
    AIDS Alert; 2007 Dec; 22(12):144. PubMed ID: 18411486
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA approves two combo brand-name AIDS drugs.
    Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. Tentative approval for lamivudine.
    AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA grants tentative approval to two ART drugs under expedited review.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580369
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Tenofovir in India receives tentative approval.
    AIDS Alert; 2009 Jun; 24(6):70-1. PubMed ID: 19544609
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. FDA grants tentative approval to generic stavudine.
    AIDS Alert; 2006 Feb; 21(2):24. PubMed ID: 16562341
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. FDA grants tentative approval to generic Nevirapine.
    AIDS Alert; 2006 Feb; 21(2):23-4. PubMed ID: 16562340
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
    James JS
    AIDS Treat News; 2004 Jul; (403):6. PubMed ID: 15386855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA notifications. Tentative approval for generic stavudine, oral solution.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. FDA's tentative approval for generic Tenofovir.
    AIDS Alert; 2008 Jan; 23(1):11-2. PubMed ID: 18572475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.